Michael Smith (chemist)

Michael Smith (chemist). Michael Smith was a British-born Canadian biochemist whose pioneering work in site-directed mutagenesis revolutionized molecular biology and protein engineering. His technique, developed in the late 1970s and early 1980s, allowed scientists to precisely alter the DNA sequence of genes, enabling the study of protein function and the development of novel enzymes and therapeutics. For this foundational contribution, he was awarded the Nobel Prize in Chemistry in 1993, sharing the honor with Kary Mullis.

Early life and education

Michael Smith was born in Blackpool, Lancashire, and developed an early interest in chemistry. He pursued his undergraduate studies at the University of Manchester, earning a Bachelor of Science degree in chemistry in 1953. He continued his research at the same institution under the supervision of H. B. Henbest, focusing on steroid chemistry and earning his Doctor of Philosophy in 1956. A pivotal postdoctoral fellowship brought him to the laboratory of Gobind Khorana at the University of British Columbia and later at the University of Wisconsin–Madison, where he was introduced to the burgeoning field of nucleic acid chemistry.

Career and research

Smith joined the faculty of the University of British Columbia in 1960, where he would spend the majority of his career. His early work involved studying the genetic code and oligonucleotide synthesis. In 1978, while on a sabbatical at the Medical Research Council Laboratory of Molecular Biology in Cambridge, he conceived the method of site-directed mutagenesis. This technique used synthetic oligonucleotides to introduce specific, predetermined changes into a cloned gene, allowing researchers to probe the relationship between gene structure and protein function. His laboratory at the University of British Columbia refined the method, and it quickly became a cornerstone technology in laboratories worldwide, impacting fields from biochemistry to biotechnology.

Awards and honors

Smith's contributions were recognized with numerous prestigious awards. He received the Gairdner Foundation International Award in 1986. In 1992, he was awarded the Flavelle Medal by the Royal Society of Canada. The pinnacle of his recognition came in 1993 when he was co-awarded the Nobel Prize in Chemistry. He was also appointed a Companion of the Order of Canada, one of the country's highest civilian honors. Furthermore, he was elected a fellow of the Royal Society of London and the Royal Society of Canada.

Personal life

Smith emigrated to Canada in 1956 and became a naturalized citizen. He was known for his modesty and dedication to both science and public service. Following his Nobel Prize win, he donated his prize money to support research in schizophrenia and to fund science education and outreach programs in British Columbia. He was married to Helen Christie and had four children. Smith passed away in Vancouver in 2000 from cancer.

Legacy

Michael Smith's development of site-directed mutagenesis is considered one of the most important methodological advances in modern biology. It laid the groundwork for the entire field of protein engineering and is essential for drug discovery, the study of genetic diseases, and the development of industrial biocatalysts. The Michael Smith Laboratories at the University of British Columbia were named in his honor, continuing his legacy of interdisciplinary research. His work fundamentally changed how scientists manipulate and understand the molecules of life.

Category:Canadian biochemists Category:Nobel laureates in Chemistry Category:University of British Columbia faculty